Centers for Disease Control and Prevention. (2021). Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recommendations and Reports, 70(4), 1-187.
[2]
World Health Organization. (2021). WHO Guidelines on the Treatment of Chlamydia trachomatis Infections. Geneva: WHO Press.
[3]
Brunham, R. C., & Rey-Ladino, J. (2020). Immunology of Chlamydia infection: implications for Chlamydia vaccine development. Annual Review of Immunology, 38, 235-256.
[4]
Haggerty, C. L., et al. (2019). Risk of sequelae after Chlamydia trachomatis genital infection in women. Journal of Infectious Diseases, 201(S2), S134-S145.
[5]
Peters, R. P., et al. (2020). The prevalence of Chlamydia trachomatis infection in Indonesia: a systematic review. International Journal of Infectious Diseases, 96, 456-463.
[6]
Kreisel, K. M., et al. (2021). Sexually transmitted infections in the United States: overview and update. Clinical Microbiology Reviews, 34(1), e00100-19.
[7]
Mishima, E., et al. (2020). Fitz-Hugh-Curtis syndrome: a review of the literature and current management. Journal of Obstetrics and Gynaecology Research, 46(8), 1423-1431.
[8]
Indonesian Society of Obstetrics and Gynecology. (2019). Panduan Praktik Klinis: Infeksi Saluran Reproduksi. Jakarta: POGI Press.